Citation Tools
PDFRegular and young investigator award abstracts
Checkpoint blockade therapy
215 AO-176, a highly differentiated clinical stage anti-CD47 antibody, preferentially binds tumor versus normal cell CD47 when complexed to β1 integrin
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 215 AO-176, a highly differentiated clinical stage anti-CD47 antibody, preferentially binds tumor versus normal cell CD47 when complexed to β1 integrin